Sabrina Herrera

Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 Therapy

Mario Giuliano, Huizhong Hu, Yen-Chao Wang et al. · Clinical Cancer Research · 2015 · 118 citations · Full text

Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer

Mothaffar F. Rimawi, Carmine De Angelis, Alejandro Contreras et al. · Breast Cancer Research and Treatment · 2017 · 92 citations · Full text

Breast Oncology, Medicine, Pathology +8

Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase

Xiaoyong Fu, Chad J. Creighton, Nrusingh C. Biswal et al. · Breast Cancer Research · 2014 · 70 citations · Full text

Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis

Mario Giuliano, Sabrina Herrera, Pavel Christiny et al. · Breast Cancer Research · 2015 · 56 citations · Full text

A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancer

Jamunarani Veeraraghavan, Carmine De Angelis, Rena Mao et al. · Annals of Oncology · 2019 · 41 citations · Full text